George M Jenkins bought $52k of PVLA
director at PALVELLA THERAPEUTICS, INC.. 4,000 shares at an average of $12.93, traded Dec 18, 2024, filed Dec 19, 2024.
Score components
- +15RoleDirector
- +7Trade size$52k at market
- 0Relative to holdingsHoldings up 2.3%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-020879, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2024 | POpen-market purchase Common Stock | +4,000 | $12.93 | $52k | 180,671 | Dec 19, 2024 |
Related signals
Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 40Moderate | PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $4.2M 27,500 shares | -15% | |
| 42Moderate | PALVELLA THERAPEUTICS, INC. | Christopher P Kiritsy director | $49k 313 shares | -56% | |
| 21Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $415k 4,302 shares | -100% | |
| 20Weak | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $371k 4,302 shares | -100% | |
| 29Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $101k 4,990 shares | +3% | |
| 23Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | James A Geraghty director | $1 1 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.